Industry, regulators in frank discussion at 5th India Pharma Summit
DoP, WHO and FICCI event focused strengthening infrastruture, clarifying regulations pertaining to APIs, drug trials, R&D
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
HIV Congress 2014 deliberates upon strategies for fighting HIV epidemic
700 participants took part in the event
Daiichi Sankyo India, Ranbaxy & Royal Society Chemistry organise symposium
Declare Research Awards 2012, honour five outstanding scientists and five young science scholars
US FDA approves Myalept to treat rare metabolic disease
The safety and effectiveness of Myalept, an analogue of leptin made through recombinant DNA technology, were evaluated in an…
Jubilant Life Sciences resolution for Montreal facility
Jubilant Life Sciences has received a communication from the US Food and Drug Administration (US FDA), classifying its…
Biomarker discovery presents opportunities for players in Parkinson’s Disease market:…
GlobalData predicts PD prevalence to increase from 2.5 million patients to 3.2 million across the seven major markets
Lupin receives approval for acne treatment
Lupin has received final approval for its Doxycycline capsules USP, 50 mg, 75 mg, and 100 mg from the United States Food and Drugs…
Claris Lifesciences posts consolidated revenues at Rs 7,084 million
EBITDA margin reported at Rs 2,100 million
Strand receives US patent for virtual liver model
Announces release of the human version of the virtual liver model